The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer

Detalles Bibliográficos
Autor principal: He, Shenghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447629/
https://www.ncbi.nlm.nih.gov/pubmed/32843656
http://dx.doi.org/10.1038/s41392-020-00283-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447629/
https://www.ncbi.nlm.nih.gov/pubmed/32843656
http://dx.doi.org/10.1038/s41392-020-00283-8

Ejemplares similares